➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Merck
Mallinckrodt
Johnson and Johnson
Harvard Business School

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for Ely Holdings Limited v. O'Keeffe's, Inc. (N.D. Cal. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Ely Holdings Limited v. O'Keeffe's, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Ely Holdings Limited v. O'Keeffe's, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Ely Holdings Limited v. O'Keeffe's, Inc. (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2019-12-18 112 Order 2 ’475 Patent at 8:39–10:24 (emphasis added). …infringed U.S. Patent No. 15 7,694,475 (the “’475 patent”), which relates…It is a ‘bedrock principle’ of patent law that ‘the claims of a patent define the invention to …history of a patent to 5 understand how the patent applicant and…including U.S. Patent No. 5,027,567 20 (the “Roberts patent” or the “’ External link to document
2020-06-05 167 Substitute Attorney Case 3:18-cv-06721-JCS Document 167 Filed 06/05/20 Page 1 of 4 … Case 3:18-cv-06721-JCS Document 167 Filed 06/05/20 Page 2 of 4 … Case 3:18-cv-06721-JCS Document 167 Filed 06/05/20 Page 3 of 4 … Case 3:18-cv-06721-JCS Document 167 Filed 06/05/20 Page 4 of 4 … 5 November 2018 3:18-cv-06721 830 Patent Plaintiff District Court, N.D. California External link to document
2020-12-30 207 Reply to Opposition/Response -06721-JCS Document 207 Filed 12/30/20 Page 6 of 20 1 claim that no “GPX floor with an air layer… (“FWD”) of the 15 Patent Trial & Appeal Board (“PTAB”) at the U.S. Patent & Trademark Office… post grant 16 review of U.S. Patent No. 9,926,709 (“the ‘709 patent”). Among its factual findings, …the ‘475 patent and the possibility that Defendant’s product might 17 infringe that patent, two facts…G. The ‘475 Patent is Valid. 27 Defendant argues that claim 1 of the ‘475 patent is not valid External link to document
2021-02-02 214 Order on Motion for Partial Summary Judgment AND Order on Motion for Leave to File AND Order on Motion to Strike AND Order on Motion to Strike AND Order on Motion for Summary Judgment 16 ’475 Patent at 8:39–9:64. Although Plaintiffs’ operative complaint…asserted counterclaims. Plaintiffs’ patent at issue is U.S. Patent …on prior art that was before the patent examiners when the ’475 patent …in the patent because beams are identified 26 in the patent’s claims… 2 patent identified by Dr. Stevick was cited during the examination of the ’475 patent, that like External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Medtronic
McKesson
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.